Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
289.40    16.80 (6.16%)
Bid:
289.00
Ask:
289.40
Spread: 0.40 (0.138%)
Market Cap: £729.25m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Director/PDMR Shareholding

7 May 2021 17:23

RNS Number : 9888X
Genuit Group PLC
07 May 2021
 

Genuit Group plc (the "Company")

 

Notification of transactions by Person Discharging Managerial Responsibilities

 

The Company announces that on 4 May 2021, Glen Sabin, Chief Operating Officer and a Person Discharging Managerial Responsibilities, exercised the following options:

 

1. a nil-cost option over 18,376 shares in accordance with the Long Term Incentive Plan Award granted to him on 2 May 2018. Mr. Sabin sold all exercised shares with the appropriate tax and national insurance liabilities deducted from the sale proceeds.

 

2. a nil-cost option over a total of 1,537 shares (comprising 1,482 shares granted under the Award and 55 shares awarded at vesting in lieu of dividends paid during the vesting period) in accordance with the Deferred Share Bonus Plan Award granted to him on 2 May 2018. Mr. Sabin sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.

 

3. a nil-cost option over a total of 4,141 shares (comprising 4,027 shares granted under the Award and 114 shares awarded at vesting in lieu of dividends paid during the vesting period) in accordance with the Deferred Share Bonus Plan Award granted to him on 30 April 2019. Mr. Sabin sold sufficient shares to cover the appropriate tax and national insurance liabilities due on exercise.

 

Mr. Sabin now holds an interest in a total of 716,574 shares.

 

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Glen Sabin

2

Reason for the notification

a)

Position/status

Chief Operating Officer/Director and PDMR

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Genuit Group plc

b)

LEI

2138005IF1N2RKJ6KO18

 

 

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares ("Shares") of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

b)

Nature of the transaction

Sale of Shares acquired for no consideration pursuant to the exercise of nil-cost options in accordance with the Long Term Incentive Plan ("LTIP") award granted on 2 May 2018.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£5.68

18,376

 

 

d)

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

18,376

 

 

£5.68

e)

Date of the transaction

6 May 2021

f)

Place of the transaction

Outside a Trading Venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Glen Sabin

2

Reason for the notification

a)

Position/status

Chief Operating Officer/Director and PDMR

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Genuit Group plc

b)

LEI

2138005IF1N2RKJ6KO18

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares ("Shares") of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

b)

Nature of the transaction

Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options as follows: Deferred Share Bonus Plan ("DSBP") award granted on 2 May 2018.

Deferred Share Bonus Plan ("DSBP") award granted on 30 April 2019.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

Nil

818 - Number of DSBP shares acquired from

2 May 2018 grant after reduction for appropriate tax and national insurance liabilities.

 

 

 

 

 

 

2,204 - Number of DSBP shares acquired from 30 April 2019 grant after reduction for appropriate tax and national insurance

liabilities.

 

 

d)

Aggregated information

 

 

- Aggregated volume

 

 

- Price

N/A

e)

Date of the transaction

6 May 2021

f)

Place of the transaction

Outside a Trading Venue

 

 

Enquiries:

 

Emma Versluys, Company Secretary

+44 (0) 1709 770 000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKOBBABKDDPK
Date   Source Headline
23rd Dec 20259:06 amRNSHolding(s) in Company
16th Dec 20252:03 pmRNSHolding(s) in Company
16th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20253:41 pmRNSDirector/PDMR Shareholding
10th Dec 20254:11 pmRNSDirector/PDMR Shareholding
9th Dec 202510:44 amRNSHolding(s) in Company
3rd Dec 20255:11 pmRNSHolding(s) in Company
3rd Dec 20254:56 pmRNSDirector/PDMR Shareholding
3rd Dec 20254:39 pmRNSDirector/PDMR Shareholding
3rd Dec 202510:00 amRNSHolding(s) in Company
2nd Dec 20255:09 pmRNSHolding(s) in Company
27th Nov 20254:49 pmRNSHolding(s) in Company
18th Nov 20254:28 pmRNSBlock Listing Application
18th Nov 20253:31 pmRNSDirector/PDMR Shareholding
17th Nov 20257:00 amRNSTrading Update
10th Nov 202511:40 amRNSHolding(s) in Company
7th Nov 20252:26 pmRNSHolding(s) in Company
3rd Nov 202510:00 amRNSBlock listing Interim Review
15th Oct 20251:30 pmRNSDirector/PDMR Shareholding
30th Sep 20253:51 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAcquisition of Davidson Holdings
18th Sep 20253:26 pmRNSDirectorate Change
1st Sep 20257:00 amRNSAcquisition of Monodraught
19th Aug 20256:11 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSHalf-year Report
26th Jun 20254:21 pmRNSDirector/PDMR Shareholding
20th Jun 20254:22 pmRNSDirectorate Change
19th May 20251:37 pmRNSResult of AGM
19th May 20257:00 amRNSTrading Statement
1st May 202512:26 pmRNSBlock listing Interim Review
15th Apr 20259:49 amRNSNotice of AGM
11th Mar 20257:00 amRNSFinal Results
21st Feb 20254:25 pmRNSHolding(s) in Company
14th Feb 20255:00 pmRNSHolding(s) in Company
28th Jan 202510:05 amRNSHolding(s) in Company
21st Jan 20251:53 pmRNSHolding(s) in Company
2nd Jan 202510:01 amRNSHolding(s) in Company
23rd Dec 20242:58 pmRNSHolding(s) in Company
19th Dec 20243:20 pmRNSDirector/PDMR Shareholding
17th Dec 202412:32 pmRNSHolding(s) in Company
12th Dec 20245:25 pmRNSHolding(s) in Company
25th Nov 20241:01 pmRNSDirector/PDMR Shareholding
19th Nov 20245:55 pmRNSHolding(s) in Company
19th Nov 20247:00 amRNSTrading Update
15th Nov 20243:10 pmRNSHolding(s) in Company
1st Nov 20241:37 pmRNSBlock listing Interim Review
31st Oct 20241:14 pmRNSHolding(s) in Company
11th Oct 202412:23 pmRNSHolding(s) in Company
7th Oct 20244:05 pmRNSHolding(s) in Company
9th Sep 20245:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.